✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine · NabkaNews

← Back to headlines

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

The New York Times·Feb 18

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The US Food and Drug Administration has reversed a previous decision and will review Moderna's flu vaccine application. The vaccine in question is an mRNA-based flu vaccine. The reason for the reversal is not universally agreed upon, with some reports suggesting external pressure may have played a role.

Full coverage

FDA reverses course on Moderna flu shot

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

FDA reverses course, agrees to review Moderna’s flu vaccine

FDA reverses course and will review Moderna’s mRNA-based flu vaccine

The Guardian·Feb 18

US FDA reverses course, will review Moderna's flu vaccine application

Reuters·Feb 18

US FDA reverses course, will review Moderna's revised flu vaccine application

Yahoo Finance·Feb 18

FDA's reversal on Moderna flu shot bid followed White House pressure

Politico·Feb 18

FDA reverses course and will review Moderna’s mRNA flu shot, company says

View original report at The New York Times ↗